Evidence map›Paper›PMID 38881466›Full record

ArticleHypertension (Dallas, Tex. : 1979)2024

Chronic Hypertension During Pregnancy: Prevalence and Treatment in the United States, 2008-2021.

Stephanie A Leonard, Sara Siadat, Elliott K Main, Krista F Huybrechts, Yasser Y El-Sayed, Mark A Hlatky, Jheanelle Atkinson, Ayesha Sujan, Brian T Bateman

Abstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Gestational ages-specific blood pressure patterns and risk of adverse pregnancy outcomes in women with chronic hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Food desert residence and prenatal diet quality.Pregnancy (Hoboken, N.J.) · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Stephanie A LeonardDepartment of Obstetrics and Gynecology (S.A.L., E.K.M., Y.Y.E.-S.), Stanford University School of Medicine, CA.ORCID 0000-0001-8213-1319
Sara SiadatDepartment of Anesthesiology, Perioperative and Pain Medicine (S.S., A.S., B.T.B.), Stanford University School of Medicine, CA.ORCID 0000-0002-1972-7977
Elliott K MainDepartment of Obstetrics and Gynecology (S.A.L., E.K.M., Y.Y.E.-S.), Stanford University School of Medicine, CA.ORCID 0000-0001-7562-7850
Krista F HuybrechtsDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (K.F.H.).ORCID 0000-0001-5805-8430
Yasser Y El-SayedDepartment of Obstetrics and Gynecology (S.A.L., E.K.M., Y.Y.E.-S.), Stanford University School of Medicine, CA.
Mark A HlatkyDepartments of Health Policy and Medicine (M.A.H.), Stanford University School of Medicine, CA.ORCID 0000-0003-4686-9441
Jheanelle AtkinsonMeharry Medical College, Nashville, TN (J.A.).
Ayesha SujanDepartment of Anesthesiology, Perioperative and Pain Medicine (S.S., A.S., B.T.B.), Stanford University School of Medicine, CA.ORCID 0000-0002-4374-9949
Brian T BatemanDepartment of Anesthesiology, Perioperative and Pain Medicine (S.S., A.S., B.T.B.), Stanford University School of Medicine, CA.

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and riskR01HL139844 · NHLBI · STANFORD UNIVERSITY · PI HLATKY, MARK A., WINN, VIRGINIA D · 2018 to 2021
$9.0M
Optimizing treatment of chronic hypertension in pregnancy using a national distributed data networkK01HL171699 · NHLBI · STANFORD UNIVERSITY · PI Stephanie A. Leonard · 2024 to 2026
$514k
NCATS NIH HHS UL1 TR003142NHLBI NIH HHS K01 HL171699NHLBI NIH HHS R01 HL139844
6 · The paper itself

Abstract

backgroundTreatment of chronic hypertension during pregnancy has been shown to reduce the risk of adverse perinatal outcomes. In this study, we examined the prevalence and treatment of chronic hypertension during pregnancy and assessed changes in these outcomes following the release of the updated 2017 hypertension guidelines of the American College of Cardiology and American Heart Association.

methodsWe analyzed the Merative

resultsThe prevalence of chronic hypertension steadily increased from 1.8% to 3.7% among 1 900 196 pregnancies between 2008 and 2021. Antihypertensive medication use among pregnant individuals with chronic hypertension was relatively stable (57%-60%) over the study period. The proportion of pregnant individuals with chronic hypertension treated with methyldopa or hydrochlorothiazide decreased (from 29% to 2% and from 11% to 5%, respectively), while the proportion treated with labetalol or nifedipine increased (from 19% to 42% and from 9% to 17%, respectively). The prevalence or treatment of chronic hypertension during pregnancy did not change following the 2017 American College of Cardiology and American Heart Association hypertension guidelines.

conclusionsThe prevalence of chronic hypertension during pregnancy doubled between 2008 and 2021 in a nationwide cohort of individuals with commercial insurance. Labetalol replaced methyldopa as the most commonly used antihypertensive during pregnancy. However, only about 60% of individuals with chronic hypertension in pregnancy were treated with antihypertensive medications.

Indexed as

Antihypertensive AgentsAdultChronic DiseaseFemaleHumansHypertensionHypertension, Pregnancy-InducedPregnancyPregnancy Complications, CardiovascularPrevalenceUnited StatesYoung AdultAntihypertensive Agentsantihypertensive agentshypertensioninterrupted time series analysislabetalolmethyldopanifedipinepregnancy

Identifiers

PMID38881466
PMCPMC11254556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.